Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Robert C Bast

Showing results (1-10 of 246) with videos related to

Pageof 25
Sort By:
Cancer|June 22, 2010
CA 125 and the detection of recurrent ovarian cancer: a reasonably accurate biomarker for a difficult diseaseRobert C Bast
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 14, 2003
Status of tumor markers in ovarian cancer screeningRobert C Bast
Transactions of the American Clinical and Climatological Association|October 25, 2006
Early detection of ovarian cancer: new technologies in pursuit of a disease that is neither common nor rareRobert C Bast
Cancer Biomarkers : Section a of Disease Markers|November 3, 2011
Biomarkers for ovarian cancer: new technologies and targets to address persistently unmet needsRobert C Bast
Disease Markers|December 7, 2007
Early detection of ovarian cancerDonna Badgwell, Robert C Bast
Endocrinology|March 15, 2012
Minireview: human ovarian cancer: biology, current management, and paths to personalizing therapyIgnacio Romero, Robert C Bast
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|December 2, 2020
The National Cancer Institute Early Detection Research Network: Two Decades of ProgressRobert C Bast, Sudhir Srivastava
Cancer Treatment and Research|September 19, 2009
Tumor suppressor genesZhen Lu, Robert C Bast
Nature Reviews. Clinical Oncology|September 30, 2010
Chemotherapy: A new standard combination for recurrent ovarian cancer?Robert C Bast, Maurie Markman
Cell Adhesion & Migration|January 30, 2013
The tumor suppressor gene ARHI (DIRAS3) inhibits ovarian cancer cell migration through multiple mechanismsZhen Lu, Robert C Bast
Pageof 25

Showing results (1-10 of 246) with videos related to

Sort By:
Pageof 25
Cancer|June 22, 2010
CA 125 and the detection of recurrent ovarian cancer: a reasonably accurate biomarker for a difficult diseaseRobert C Bast
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 14, 2003
Status of tumor markers in ovarian cancer screeningRobert C Bast
Transactions of the American Clinical and Climatological Association|October 25, 2006
Early detection of ovarian cancer: new technologies in pursuit of a disease that is neither common nor rareRobert C Bast
Cancer Biomarkers : Section a of Disease Markers|November 3, 2011
Biomarkers for ovarian cancer: new technologies and targets to address persistently unmet needsRobert C Bast
Disease Markers|December 7, 2007
Early detection of ovarian cancerDonna Badgwell, Robert C Bast
Endocrinology|March 15, 2012
Minireview: human ovarian cancer: biology, current management, and paths to personalizing therapyIgnacio Romero, Robert C Bast
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|December 2, 2020
The National Cancer Institute Early Detection Research Network: Two Decades of ProgressRobert C Bast, Sudhir Srivastava
Cancer Treatment and Research|September 19, 2009
Tumor suppressor genesZhen Lu, Robert C Bast
Nature Reviews. Clinical Oncology|September 30, 2010
Chemotherapy: A new standard combination for recurrent ovarian cancer?Robert C Bast, Maurie Markman
Cell Adhesion & Migration|January 30, 2013
The tumor suppressor gene ARHI (DIRAS3) inhibits ovarian cancer cell migration through multiple mechanismsZhen Lu, Robert C Bast
Pageof 25